Search results
Prometheus Laboratories Announces New Health Plan Agreements to Provide Precision-Guided Testing...
Digital Journal· 2 days ago...annually in the US 1 , yet up to two-thirds of patients fail therapy, largely due to unoptimized dosing. 2 PredictrPK is a clinically useful and cost-effective tool to help optimize biologic treatment and prevent unnecessary patient suffering, flares, surgeries, and hospitalizations. 3,4...
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlight
Guru Focus· 5 days agoAsset Sale: Agreement to sell Bio-Reference health assets to LabCorp for $237.5 million.Revenue: Q1 2024 revenue for Diagnostics segment reported at $126.9 mil
Tackling a Pathogen That Leaves a Lasting Impression
The Scientist· 6 days agoIn a recently published Cell Reports Medicine paper, researchers determined that previous exposures to the pathogen affect vaccine efficacy, where they...
BioAtla gets FDA nod for new cancer drug trial By Investing.com
Investing.com· 5 days agoAdministration (FDA) has approved its investigational new drug (IND) application. This clearance...
Outbreak of Highly Pathogenic Avian Influenza A(H5N1) Virus in Seals, St. Lawrence Estuary, Quebec,...
Centers for Disease Control and Prevention· 3 days agoAvian Influenza A(H5N1) Virus in Seals, Canada
OPKO Health Inc (OPK) Q1 2024 Earnings Call Transcript Highlights: Strategic Moves Amid ...
GuruFocus.com via Yahoo Finance· 4 days agoCost of Expenses: Decreased to $161.3 million in Q1 2024 from $172.4 million in Q1 2023. Pharmaceuticals Operating Loss: $27.7 million in Q1 2024 compared to... (NASDAQ:OPK ...
New portable fentanyl sensor is super sensitive
Futurity· 4 days agoA new fentanyl sensor is six orders of magnitude more sensitive than any electrochemical sensor for the drug reported in the past five years. The...
What are the new COVID FLiRT variants, and are they in Wisconsin?
Gannett via AOL· 3 days agoSymptoms may appear two to 14 days after exposure. Latest COVID guidance from the CDC In March 2024,...
Learn About How Xolair can Protect Against Food Allergies
1011 News· 4 days agoThe following content is created on behalf of Allergy, Asthma, and Immunology and does not reflect...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoPRESS RELEASE - 06/05/2024, 07:00 CEST Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region Biocartis (Mechelen, Belgium) announced an expansion of its collaboration